| Autor: |
Matchett, Gerald, Gasanova, Irina, Riccio, Christina A., Nasir, Dawood, Sunna, Mary C., Bravenec, Brian J., Azizad, Omaira, Farrell, Brian, Minhajuddin, Abu, Stewart, Jesse W., Liang, Lawrence W., Moon, Tiffany Sun, Fox, Pamela E., Ebeling, Callie G., Smith, Miakka N., Trousdale, Devin, Ogunnaike, Babatunde O., the EvK Clinical Trial Collaborators, Abraham, Anand M., Ackerman, Robert S. |
| Předmět: |
|
| Zdroj: |
Intensive Care Medicine; Jan2022, Vol. 48 Issue 1, p78-91, 14p, 1 Diagram, 3 Charts, 1 Graph |
| Abstrakt: |
Purpose: Etomidate and ketamine are hemodynamically stable induction agents often used to sedate critically ill patients during emergency endotracheal intubation. In 2015, quality improvement data from our hospital suggested a survival benefit at Day 7 from avoidance of etomidate in critically ill patients during emergency intubation. In this clinical trial, we hypothesized that randomization to ketamine instead of etomidate would be associated with Day 7 survival after emergency endotracheal intubation. Methods: A prospective, randomized, open-label, parallel assignment, single-center clinical trial performed by an anesthesiology-based Airway Team under emergent circumstances at one high-volume medical center in the United States. 801 critically ill patients requiring emergency intubation were randomly assigned 1:1 by computer-generated, pre-randomized sealed envelopes to receive etomidate (0.2–0.3 mg/kg, n = 400) or ketamine (1–2 mg/kg, n = 401) for sedation prior to intubation. The pre-specified primary endpoint of the trial was Day 7 survival. Secondary endpoints included Day 28 survival. Results: Of the 801 enrolled patients, 396 were analyzed in the etomidate arm, and 395 in the ketamine arm. Day 7 survival was significantly lower in the etomidate arm than in the ketamine arm (77.3% versus 85.1%, difference − 7.8, 95% confidence interval − 13, − 2.4, p = 0.005). Day 28 survival rates for the two groups were not significantly different (etomidate 64.1%, ketamine 66.8%, difference − 2.7, 95% confidence interval − 9.3, 3.9, p = 0.294). Conclusion: While the primary outcome of Day 7 survival was greater in patients randomized to ketamine, there was no significant difference in survival by Day 28. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink